These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34167321)

  • 1. Paired sensitivity analysis of four SARS-CoV-2 serological immunoassays in a longitudinal cohort of convalescent hospital staff.
    Sim M; Cockcroft C; Darby D; Ellis CR; Heaps A; Scargill J; Garcez T
    Ann Clin Biochem; 2021 Nov; 58(6):646-649. PubMed ID: 34167321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection.
    Bond KA; Williams E; Nicholson S; Lim S; Johnson D; Cox B; Putland M; Gardiner E; Tippett E; Graham M; Mordant F; Catton M; Lewin SR; Subbarao K; Howden BP; Williamson DA
    Pathology; 2021 Oct; 53(6):773-779. PubMed ID: 34412859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.
    Poore B; Nerenz RD; Brodis D; Brown CI; Cervinski MA; Hubbard JA
    Clin Biochem; 2021 Sep; 95():77-80. PubMed ID: 34118242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
    National SARS-CoV-2 Serology Assay Evaluation Group
    Lancet Infect Dis; 2020 Dec; 20(12):1390-1400. PubMed ID: 32979318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
    Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
    J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Tancevski I; Weiss G; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 May; 59(6):1143-1154. PubMed ID: 33554557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
    Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
    Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
    Front Immunol; 2020; 11():609242. PubMed ID: 33424863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An original multiplex method to assess five different SARS-CoV-2 antibodies.
    Favresse J; Brauner J; Bodart N; Vigneron A; Roisin S; Melchionda S; Douxfils J; Ocmant A
    Clin Chem Lab Med; 2021 Apr; 59(5):971-978. PubMed ID: 33554567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population.
    Wehrhahn MC; Brown SJ; Newcombe JP; Chong S; Evans J; Figtree M; Hainke L; Hueston L; Khan S; Marland E; O'Sullivan MVN; Powell H; Roy J; Waring L; Yu M; Robson J
    J Clin Virol; 2021 May; 138():104797. PubMed ID: 33770657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four high-throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies.
    Oakey J; Haslam S; Brown A; Eglin J; Houghton B; Singleton D
    Ann Clin Biochem; 2021 Sep; 58(5):487-495. PubMed ID: 33892600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples.
    Manthei DM; Whalen JF; Schroeder LF; Sinay AM; Li SH; Valdez R; Giacherio DA; Gherasim C
    Am J Clin Pathol; 2021 Feb; 155(2):267-279. PubMed ID: 33033840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies.
    Schallier A; De Baets S; De Bruyne D; Dauwe K; Herpol M; Couck P
    Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115403. PubMed ID: 34058541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.
    Tan SS; Saw S; Chew KL; Huak CY; Khoo C; Pajarillaga A; Wang W; Tambyah P; Ong L; Jureen R; Sethi SK
    Pathology; 2020 Dec; 52(7):770-777. PubMed ID: 33092816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.